- Telehealth Visits
- Insurance plan information
Nicholas Fleming, MD, MPP
Internal Medicine- Telehealth Visits
- Insurance plan information
Nicholas Fleming, MD, MPP
Internal Medicine- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Nicholas F. Fleming is a specialist in internal medicine who provides primary care.
After earning his undergraduate degree at Duke University, Fleming completed a joint medical degree and master's degree in public policy at Harvard Medical School and the Harvard John F. Kennedy School of Government. He then completed his residency training in internal medicine at Massachusetts General Hospital.
Prior to joining UCSF, Fleming worked for 14 years in a private multispecialty practice started by his father in South Carolina. During that time, Fleming held many hospital leadership positions – from chief of staff to medical director of a skilled nursing facility – and was involved in various community service activities. He was chosen for the inaugural class of the Liberty Fellowship, an Aspen Institute–based leadership development program for young professionals in South Carolina, and is now part of the Aspen Global Leadership Network.
Education & training
Board certification
- Internal Medicine, American Board of Internal Medicine
Residency
- Internal Medicine, Massachusetts General Hospital GME
Internship
- Internal Medicine, Massachusetts General Hospital GME
Degree
- MD, Harvard Medical School
My expertise
Specialties
Clinical Trials query: q=health_gateway_id_ss%3A%28%222143%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222143%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.